Koll, K. K., Zimmermann, M. M., Will, P. A., Kneser, U., & Hirche, C. The Transcription Factor SOX18 Inhibitor Small Molecule 4 Is a Potential Treatment of Cancer‐Induced Lymphatic Metastasis and Lymphangiosarcoma. Wiley.
Chicago Style (17th ed.) CitationKoll, Katja K., Martin M. Zimmermann, Patrick A. Will, Ulrich Kneser, and Christoph Hirche. The Transcription Factor SOX18 Inhibitor Small Molecule 4 Is a Potential Treatment of Cancer‐Induced Lymphatic Metastasis and Lymphangiosarcoma. Wiley.
MLA (9th ed.) CitationKoll, Katja K., et al. The Transcription Factor SOX18 Inhibitor Small Molecule 4 Is a Potential Treatment of Cancer‐Induced Lymphatic Metastasis and Lymphangiosarcoma. Wiley.
Warning: These citations may not always be 100% accurate.